| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.1M | +211.7% |
| SG&A Expense | $9.4M | +346.9% |
| Operating Income | -$13.5M | -294.5% |
| Income Tax | $3.16T | +367.5% |
| Net Income | -$13.4M | -292.7% |
| EPS (Basic) | -$1.10 | +12.7% |
| EPS (Diluted) | -$1.10 | +12.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.8M | +1235.4% |
| Current Assets | $26.3M | +754.4% |
| Total Assets | $26.3M | +752.9% |
| Current Liabilities | $3.9M | +139.4% |
| Total Liabilities | $3.9M | +139.4% |
| Stockholders' Equity | $22.4M | +1447.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.7M | -325.5% |
| Capital Expenditures | $9K | +385.4% |
| Investing Cash Flow | -$9K | -385.4% |
| Financing Cash Flow | $32.5M | +9834.8% |
| Free Cash Flow | -$8.7M | -325.6% |